🎉 M&A multiples are live!
Check it out!

China Res Double-Crane Valuation Multiples

Discover revenue and EBITDA valuation multiples for China Res Double-Crane and similar public comparables like Pharming, Vivoryon Therapeutics, and Galapagos.

China Res Double-Crane Overview

About China Res Double-Crane

China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.


Founded

1997

HQ

China
Employees

10.0K+

Website

dcpc.com

Financials

LTM Revenue $1.6B

LTM EBITDA $346M

EV

$2.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

China Res Double-Crane Financials

China Res Double-Crane has a last 12-month revenue of $1.6B and a last 12-month EBITDA of $346M.

In the most recent fiscal year, China Res Double-Crane achieved revenue of $1.5B and an EBITDA of $363M.

China Res Double-Crane expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See China Res Double-Crane valuation multiples based on analyst estimates

China Res Double-Crane P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.4B $1.5B XXX XXX XXX
Gross Profit $719M $778M XXX XXX XXX
Gross Margin 51% 50% XXX XXX XXX
EBITDA $306M $363M XXX XXX XXX
EBITDA Margin 22% 24% XXX XXX XXX
Net Profit $160M $184M XXX XXX XXX
Net Margin 11% 12% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

China Res Double-Crane Stock Performance

As of April 15, 2025, China Res Double-Crane's stock price is CNY 18 (or $3).

China Res Double-Crane has current market cap of CNY 19.1B (or $2.6B), and EV of CNY 17.4B (or $2.4B).

See China Res Double-Crane trading valuation data

China Res Double-Crane Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.4B $2.6B XXX XXX XXX XXX $0.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

China Res Double-Crane Valuation Multiples

As of April 15, 2025, China Res Double-Crane has market cap of $2.6B and EV of $2.4B.

China Res Double-Crane's trades at 1.5x LTM EV/Revenue multiple, and 6.9x LTM EBITDA.

Analysts estimate China Res Double-Crane's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for China Res Double-Crane and 10K+ public comps

China Res Double-Crane Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.4B XXX XXX XXX
EV/Revenue 1.6x XXX XXX XXX
EV/EBITDA 6.6x XXX XXX XXX
P/E 11.7x XXX XXX XXX
P/E/Growth 1.7x XXX XXX XXX
EV/FCF 14.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get China Res Double-Crane Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

China Res Double-Crane Valuation Multiples

China Res Double-Crane's NTM/LTM revenue growth is 4%

China Res Double-Crane's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, China Res Double-Crane's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate China Res Double-Crane's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for China Res Double-Crane and other 10K+ public comps

China Res Double-Crane Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 10% XXX XXX XXX XXX
EBITDA Margin 24% XXX XXX XXX XXX
EBITDA Growth 19% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 28% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 20% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue 5% XXX XXX XXX XXX
Opex to Revenue 42% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

China Res Double-Crane Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

China Res Double-Crane M&A and Investment Activity

China Res Double-Crane acquired  XXX companies to date.

Last acquisition by China Res Double-Crane was  XXXXXXXX, XXXXX XXXXX XXXXXX . China Res Double-Crane acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by China Res Double-Crane

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About China Res Double-Crane

When was China Res Double-Crane founded? China Res Double-Crane was founded in 1997.
Where is China Res Double-Crane headquartered? China Res Double-Crane is headquartered in China.
How many employees does China Res Double-Crane have? As of today, China Res Double-Crane has 10.0K+ employees.
Is China Res Double-Crane publicy listed? Yes, China Res Double-Crane is a public company listed on SHG.
What is the stock symbol of China Res Double-Crane? China Res Double-Crane trades under 600062 ticker.
When did China Res Double-Crane go public? China Res Double-Crane went public in 1997.
Who are competitors of China Res Double-Crane? Similar companies to China Res Double-Crane include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of China Res Double-Crane? China Res Double-Crane's current market cap is $2.6B
What is the current revenue of China Res Double-Crane? China Res Double-Crane's last 12-month revenue is $1.6B.
What is the current EBITDA of China Res Double-Crane? China Res Double-Crane's last 12-month EBITDA is $346M.
What is the current EV/Revenue multiple of China Res Double-Crane? Current revenue multiple of China Res Double-Crane is 1.5x.
What is the current EV/EBITDA multiple of China Res Double-Crane? Current EBITDA multiple of China Res Double-Crane is 6.9x.
What is the current revenue growth of China Res Double-Crane? China Res Double-Crane revenue growth between 2023 and 2024 was 10%.
Is China Res Double-Crane profitable? Yes, China Res Double-Crane is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.